Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▼ | Descriptor |
|---|---|---|---|
| 8A1F | Q15262 | Human PTPRK N-terminal domains MAM-Ig-FN1 | |
| 8DBN | P60891 | Human PRPS1-E307A engineered mutation with Phosphate, ATP, and R5P; Hexamer | |
| 8DBK | P60891 | Human PRPS1 with Phosphate, ATP, and R5P; Hexamer with resolved catalytic loops | |
| 8DBI | P60891 | Human PRPS1 with Phosphate, ATP, and R5P; Hexamer | |
| 8DBJ | P60891 | Human PRPS1 with Phosphate, ATP, and R5P; Filament Interface | |
| 8DBL | P60891 | Human PRPS1 with Phosphate and PRPP; Hexamer | |
| 8DBM | P60891 | Human PRPS1 with Phosphate and PRPP; Filament Interface | |
| 8DBE | P60891 | Human PRPS1 with ADP; Hexamer | |
| 8DBF | P60891 | Human PRPS1 with ADP; Filament Interface | |
| 5U3Y | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 9 | |
| 5U3X | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 8 | |
| 5U3W | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 7 | |
| 5U3V | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 6 | |
| 5U3U | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 5 | |
| 5U3T | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 4 | |
| 5U3S | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 3 | |
| 5U3R | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 2 | |
| 5U41 | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 16 | |
| 5U40 | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 15 | |
| 5U45 | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 14 | |
| 5U44 | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 13 | |
| 5U43 | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 12 | |
| 5U42 | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 11 | |
| 5U3Z | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 10 | |
| 5U3Q | Q03181 | Human PPARdelta ligand-binding domain in complexed with specific agonist 1 | |
| 5U46 | Q03181 | Human PPARdelta ligand-binding domain in complexed with GW501516 | |
| 8HF8 | Q03181 | Human PPAR delta ligand binding domain in complex with a synthetic agonist V1 | |
| 2ZNQ | Q03181 | Human PPAR delta ligand binding domain in complex with a synthetic agonist TIPP401 | |
| 2ZNP | Q03181 | Human PPAR delta ligand binding domain in complex with a synthetic agonist TIPP204 | |
| 5AK0 | Q16875 | Human PFKFB3 in complex with an indole inhibitor 6 | |
| 5AJZ | Q16875 | Human PFKFB3 in complex with an indole inhibitor 5 | |
| 5AJY | Q16875 | Human PFKFB3 in complex with an indole inhibitor 4 | |
| 5AJX | Q16875 | Human PFKFB3 in complex with an indole inhibitor 3 | |
| 5AJW | Q16875 | Human PFKFB3 in complex with an indole inhibitor 2 | |
| 5AJV | Q16875 | Human PFKFB3 in complex with an indole inhibitor 1 | |
| 6IBZ | Q16875 | Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 7 | |
| 6IBY | Q16875 | Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 6 | |
| 6IBX | Q16875 | Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 5 | |
| 6IC0 | Q16875 | Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 4 | |
| 6HVJ | Q16875 | Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 3 | |
| 6HVI | Q16875 | Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 2 | |
| 6HVH | Q16875 | Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 1 | |
| 8EQ4 | Q9H813 | Human PAC in nanodisc at pH 4.0 with PI(4,5)P2 diC8 | |
| 8FBL | Q9H813 | Human PAC in nanodisc at pH 4.0 with PI(4,5)P2 diC8 | |
| 3GCS | Q16539 | Human P38 MAP kinase in complex with Sorafenib | |
| 3GCU | Q16539 | Human P38 MAP kinase in complex with RL48 | |
| 3GCQ | Q16539 | Human P38 MAP kinase in complex with RL45 | |
| 3GCP | Q16539 | Human P38 MAP Kinase in Complex with SB203580 | |
| 3GCV | Q16539 | Human P38 MAP Kinase in Complex with RL62 | |
| 1ZYJ | Q16539 | Human P38 MAP Kinase in Complex with Inhibitor 1a |
